• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前和术后放疗在直肠癌中的作用。

The role of preoperative and postoperative radiotherapy in rectal cancer.

作者信息

Glimelius Bengt L G

机构信息

Department of Oncology, Radiology and Clinical Immunology, Section of Oncology, University Hospital, SE-751 85 Uppsala, Sweden.

出版信息

Clin Colorectal Cancer. 2002 Aug;2(2):82-92. doi: 10.3816/CCC.2002.n.014.

DOI:10.3816/CCC.2002.n.014
PMID:12453322
Abstract

Radiotherapy has an important role to play when used in addition to surgery in primary and recurrent rectal cancer. In primary resectable rectal cancer, a large number of randomized trials have shown that preoperative radiotherapy can slightly improve survival and can decrease local recurrence rates by more than half. Postoperative radiotherapy may also decrease the risk of local failure although with less efficacy. A preoperative schedule of 5 Gy/day for 5 out of 7 days is a convenient and low-toxic treatment, provided it is not given with 2 beams to large volumes, and it appears to be at least as effective as postoperative radiochemotherapy, generally meaning 6 months of therapy with 5 weeks of radiation. The schedule of 5 Gy/day for 5 days also reduces local recurrences with total mesorectal excision. It is unlikely that preoperative radiochemotherapy will substantially increase the chances of a sphincter-preserving procedure in a low-lying rectal cancer and that the long-term function will be adequate even if this is believed by many. In primary nonresectable or locally recurrent rectal cancer, preoperative radiotherapy may downsize or downstage the tumor so that it can be resected. Scientific support that radiochemotherapy is more efficient than radiotherapy alone in this situation is weak.

摘要

在原发性和复发性直肠癌中,放疗与手术联合使用时可发挥重要作用。在原发性可切除直肠癌中,大量随机试验表明,术前放疗可略微提高生存率,并可将局部复发率降低一半以上。术后放疗也可能降低局部复发风险,尽管疗效较低。每天5Gy、每周照射5天共7周的术前放疗方案是一种方便且毒性较低的治疗方法,前提是不使用两束射线照射大体积区域,而且它似乎至少与术后放化疗一样有效,通常是指为期6个月、包含5周放疗的治疗。每天5Gy、共5天的放疗方案也可减少全直肠系膜切除术后的局部复发。术前放化疗不太可能大幅增加低位直肠癌保留括约肌手术的机会,而且即使许多人认为长期功能会足够,但实际情况未必如此。在原发性不可切除或局部复发性直肠癌中,术前放疗可缩小肿瘤大小或降低肿瘤分期,从而使其能够被切除。在这种情况下,放化疗比单纯放疗更有效的科学依据并不充分。

相似文献

1
The role of preoperative and postoperative radiotherapy in rectal cancer.术前和术后放疗在直肠癌中的作用。
Clin Colorectal Cancer. 2002 Aug;2(2):82-92. doi: 10.3816/CCC.2002.n.014.
2
A systematic overview of radiation therapy effects in rectal cancer.直肠癌放射治疗效果的系统综述。
Acta Oncol. 2003;42(5-6):476-92. doi: 10.1080/02841860310012301.
3
Adjuvant radiation therapy in resectable rectal cancer: should local recurrence rates affect the decision?可切除直肠癌的辅助放疗:局部复发率是否应影响决策?
Am Surg. 1997 Jul;63(7):579-84; discussion 584-5.
4
Five fractions of preoperative radiotherapy for selected cases of rectal cancer.
Tech Coloproctol. 2004 Nov;8 Suppl 1:s36-8. doi: 10.1007/s10151-004-0106-0.
5
Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.术前超分割放化疗用于既往盆腔放疗后的局部复发性直肠癌患者:一项多中心II期研究。
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. doi: 10.1016/j.ijrobp.2005.09.017. Epub 2006 Jan 18.
6
[Local recurrence and survival rate after rectal cancer operations and multimodal therapy].[直肠癌手术及多模式治疗后的局部复发率和生存率]
Chirurg. 2002 Mar;73(3):245-54. doi: 10.1007/s00104-002-0428-2.
7
Radiotherapy and concurrent radiochemotherapy for rectal cancer.直肠癌的放射治疗与同步放化疗
Surg Oncol. 2004 Aug-Nov;13(2-3):93-101. doi: 10.1016/j.suronc.2004.08.012.
8
[Adenocarcinoma of the rectum: role of preoperative radiotherapy for the preservation of the sphincter function].[直肠癌:术前放疗对保留括约肌功能的作用]
Recenti Prog Med. 2001 Jan;92(1):41-4.
9
Transabdominal transanal resection of distal rectal cancer after high dose preoperative radiotherapy: a Chinese experience in preserving sphincter function.术前大剂量放疗后经腹经肛门切除远端直肠癌:中国保留括约肌功能的经验
Isr Med Assoc J. 2006 Oct;8(10):675-8.
10
[Adjuvant therapy of rectal cancer].[直肠癌的辅助治疗]
Tunis Med. 2003 Feb;81(2):73-9.

引用本文的文献

1
Adjuvant Radiotherapy Is Not Necessary for Stage III Mucinous Rectal Cancer: Evidence Based on Long Survival Analysis from SEER Data.辅助放疗对于 III 期直肠黏液腺癌并非必需:基于 SEER 数据的长期生存分析证据。
J Gastrointest Surg. 2023 Dec;27(12):2857-2866. doi: 10.1007/s11605-023-05765-y. Epub 2023 Nov 21.
2
Survival Benefit of Preoperative Versus Postoperative Radiotherapy in Metastatic Rectal Cancer Treated With Definitive Surgical Resection of Primary Tumor: A Population Based, Propensity Score-Matched Study.原发性肿瘤行根治性手术切除的转移性直肠癌患者术前与术后放疗的生存获益:一项基于人群的倾向评分匹配研究
J Cancer. 2019 Jan 30;10(5):1307-1312. doi: 10.7150/jca.28320. eCollection 2019.
3
Locally advanced rectal cancer: management challenges.
局部进展期直肠癌:管理挑战
Onco Targets Ther. 2016 Oct 13;9:6265-6272. doi: 10.2147/OTT.S100806. eCollection 2016.
4
Surgeon perspectives on the use and effects of neoadjuvant chemoradiation in the treatment of rectal cancer: a comprehensive review of the literature.外科医生对新辅助放化疗在直肠癌治疗中的应用及效果的观点:文献综述
Langenbecks Arch Surg. 2015 Aug;400(6):661-73. doi: 10.1007/s00423-015-1328-5. Epub 2015 Aug 7.
5
Bromodeoxyuridine labeling index as an indicator of early tumor response to preoperative radiotherapy in patients with rectal cancer.溴脱氧尿苷标记指数作为直肠癌患者术前放疗早期肿瘤反应的指标。
J Gastrointest Surg. 2007 Apr;11(4):520-8. doi: 10.1007/s11605-007-0127-x.
6
[Recurrent rectal cancer: diagnosis by contrast enhancement in MD-CT].复发性直肠癌:通过MD-CT对比增强进行诊断
Radiologe. 2005 Nov;45(11):1031-7. doi: 10.1007/s00117-004-1141-6.